Ludwig Enterprises Inc (PK) (LUDG) Quote

Damn that was a good Podcast today with tons of information, this may very well be one of the bigger OTC tickers in play and it’s not even discovered yet :-O $LUDG

Yup grabbed a batch today, she’s looking good and company updated their twitter and have been posting consistently these last two weeks $LUDG

Got some cheapies today, wow...

$LUDG Connection to Nike! This is crazy.

So the Director of Data Science at Nike’s Consumer Data Science division now worked for $LUDG on a big project.

Dr. Ambert is currently the Director of Data Science at Nike’s Consumer Data Science division after holding several positions as a data and artificial intelligence scientist. Before Nike Dr. Ambert was the Senior Deep Learning Data Scientist at Intel. His responsibilities at Intel included Data Scientist roles in Artificial Intelligence & Applied Analytics Group, Health & Life Sciences: Big Data Solutions Group and Biomedical & Big Data Research

Insane people haven’t caught on to this yet… just a matter of time

Just crazy... "By utilizing machine learning artificial intelligence (AI), this breakthrough is able identify specific mRNA genes associated with breast, colorectal, and bladder cancer."

I think this is the most unnoticed stock in the OTC right now, completely flying under the radar. Just look at the DD. Love it

It’s starting…. Finally we got a few more eyes!!! LFG

Uplisting info as well.

(OTC PINK:LUDG) Ludwig Enterprises Inc., “The Genomics Language Company” ™ the parent company of Precision Genomics Inc., and mRNA for Life Inc., is pleased to announce that they have begun the application process to be approved to trade on the OTCQB Market. This is a significant step towards achieving the company’s goal of up-listing to the NYSE. The process is expected to be completed in the near future.

So the Director of Data Science at Nike’s Consumer Data Science division now worked for $LUDG on a big project.

Dr. Ambert is currently the Director of Data Science at Nike’s Consumer Data Science division after holding several positions as a data and artificial intelligence scientist. Before Nike Dr. Ambert was the Senior Deep Learning Data Scientist at Intel. His responsibilities at Intel included Data Scientist roles in Artificial Intelligence & Applied Analytics Group, Health & Life Sciences: Big Data Solutions Group and Biomedical & Big Data Research

Here he is

https://ludwigent.com/science-leadership/

BOOOOOOOM $LUDG

What was the name of the other company that $LUDG owns?

Just look at how they are getting into AI - Cancer screen AI market.

$LUDG || Are are pleased to announce we have entered the Artificial Intelligence Cancer Screening Market and will be launching our Non-Invasive Cancer Diagnostics Testing Kit within 2024... More updates coming shortly! #OTC #AI #MachineLearning #CancerScreening #Pennystocks pic.twitter.com/83mfI7Gndu— Ludwig Enterprises Inc. | OTC:LUDG (@LUDG_inc) March 20, 2024

And this is about their current patent application

"$LUDG || As stated in our recent patent application, we have found unique genetic cancer biomarkers that will allow us to enter the billion dollar diagnostic cancer screening market. Commercialization updates coming soon"

Video proof from the CEO that they hire the current data science director of Nike!

From company "$LUDG || Very pleased to release news that our subsidiary Exousia AI is funding a preclinical study on Glioblastoma (GBM), an incurable brain cancer. "

https://t.co/6XK8lvYJ54

More LUDG. The DD is intense.

UPlisting already in progress now as well.

Now, look at how much insides NOW own.

Look at their connection to Nike! "From company: "enlisted the help of the Director of Data Sciences at Nike Inc., Dr. Kyle Ambert PhD, to develop a cancer diagnostic test"

Can't believe more people are not talking about this. $LUDG

Im holding for you LUDG...

Come on with the NEW"S.

I can't wait for the next two months, Go ludg go

🧙‍♂️Zidar On Top & Hot 🔥
🎙Interview with Dr. Marvin S. Hausman the CEO of $LUDG Ludwig Enterprises & Jose A. Reyes
🧮We discuss AI Fighting Cancer & the launch in a few months of the First-Ever at-home Cancer Test Kit
🎯Preparing to up-list this yearhttps://t.co/FN4Jlys4Db— John Zidar (@JohnZidar) May 12, 2024

LUDG,LUDG.LUDG. UP baby UP.

News...

Come on LUDG, Stop playing and go on up.

Great start this morning.

Go baby Go.

Finally News.

SPARKS, Nev., March 06, 2024 (GLOBE NEWSWIRE) -- Ludwig Enterprises, Inc. (OTC: LUDG): A US-based biotechnology company is pleased to announce the successful filing of its provisional patent, title “mRNAs differentially expressed in colorectal cancer, breast cancer, and bladder cancer.” By utilizing machine learning artificial intelligence (AI), this breakthrough is able identify specific mRNA genes associated with breast, colorectal, and bladder cancer.

These genetic findings marks a significant milestone for the company, and positions it to enter, this year, into the billion dollar diagnostic cancer screening market. The Company’s mRNA for Life™ is a one-of-the-kind noninvasive at-home sceening test for genes that could be associated with cancer. This test allows a person to make themselves a priority and could be a signal to seek a medical examination.

Ludwig, over the past 3 years, has received over 2,500 nonivasive cheek cell samples from numerous clinics in the United States as part of an IRB approved clinical study of patients with various diseases. The Company selected for measurement 48 distinct mRNA genes in stored specimens from patients afflicted with breast, bladder or colorectal cancer. mRNA levels were analyzed using machine learning artificial intelligence (AI) to identify markers of genetic expression involved in separate cancers. The filed patent application describes a method to use buccal or cheek cells as a surrogate tissue from which to isolate sufficient nanogram amounts of mRNA that can be measured in proprietary custom designed microarray chips produced by Thermo Fisher Scientific for Ludwig. Buccal cells are ideal surrogate tissues for studying levels of mRNA.

Epigenetic regulation through mRNA is an important mode of cellular control in the development of cancer. Cancer development is a complex phenomenon that involves growth factors, cytokines and extracellular enzymes that shape the environment in the tissue as well as around the cancer. It is important to define the elements of mRNA transcripts that shape and sculpt the epigenome within each cell type during each cellular reprogramming event as well as how the changing epigenomes within the tumor and stroma can act in synergy during tumor progression.

Epigenetics is the study of how a person’s behaviors and environment can cause changes that affect the way your genes work. Unlike genetic changes, epigenetic changes are reversible and do not change your DNA sequence, but they can change how your body reads a DNA sequence.

Marvin S. Hausman MD, CEO, stated: “We may have discovered a potential holy grail in medicine that uses mRNA genetic information to allow early and more accurate prediction and diagnosis of disease and disease progression. Using this unique screening via mRNA biomarkers we have uncovered cancer genetic predisposition, and enable the establishment, on a personalized basis, treatment and response to therapy.”

Come on LUDG let's go

We just need some eyes and this thing moons… been such a long hold… we deserve a nice spike. ☺️

I seen that, That's is why I posted.

$LUDG mRNA Bladder Cancer Study to be Launched

The company announced it has received Continuing Review Approval on its planned clinical study from Advarra IRB, Columbia, MD.https://t.co/axJsVMe0ak— Future Health Stocks (@FtrHealthStocks) January 31, 2024

Ludg Is blowing up.

There was news out this month. Google LUDG. Should bring it up.Sure doesn't take much to take this one up

We are having a good day so far let's make it great.

don't know no change in vol.

I see it up 35% today, something happening. Maybe the hair loss potion does work.

How about an UPDATE LUDG. YOU been very quit lately.

go go go LUDG.

Okay Ludg lets get it started.

Come on LUDG. GO GO GO.

Come on LUDG make me feel good.

Let's go Ludg with your new CEO

Here we go some news today.

At some point this will catch fire. The patent for Genome markers for inflammation is bigger than meets the eye. A whole bunch of pharma development companies will use this info.

Inflammation associated with hair loss is a completely different take on the problem. This as well has some huge potential even if only marginally effective. The supplementation formula will also affect overall improved quality of health. It will be interesting to see this develop.